These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12393392)

  • 41. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
    Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
    Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.
    Moog-Lutz C; Peterson EJ; Lutz PG; Eliason S; Cavé-Riant F; Singer A; Di Gioia Y; Dmowski S; Kamens J; Cayre YE; Koretzky G
    J Biol Chem; 2001 Jun; 276(25):22375-81. PubMed ID: 11301322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
    Jing Y
    Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines.
    Rosenauer A; Raelson JV; Nervi C; Eydoux P; DeBlasio A; Miller WH
    Blood; 1996 Oct; 88(7):2671-82. PubMed ID: 8839862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulant effects of retinoic acids on leukemia cells.
    Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
    Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
    Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Over-expression of Mcl-1 impairs the ability of ATRA to induce growth arrest and differentiation in acute promyelocytic leukemia cells.
    Yang J; Ikezoe T; Nishioka C; Yokoyama A
    Apoptosis; 2013 Nov; 18(11):1403-1415. PubMed ID: 23760752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
    Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
    Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
    Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
    Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
    Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcription therapy for acute promyelocytic leukaemia.
    Douer D
    Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
    Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2.
    Grolleau A; Wietzerbin J; Beretta L
    Leukemia; 2000 Nov; 14(11):1909-14. PubMed ID: 11069026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells.
    Zeng C; Xu Y; Xu L; Yu X; Cheng J; Yang L; Chen S; Li Y
    BMC Cancer; 2014 Sep; 14():693. PubMed ID: 25245097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
    Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
    Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
    Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.